Adderall XR faces first generic competition in US
06 April 2009
Nancy Faigen
Teva Pharmaceutical Industries has launched its generic version of
Shire's Adderall XR (amphetamine mixed salts) capsules in the US, in five strengths. Shire has been saying for some time that it expected an April 1st launch by Teva for the attention deficit hyperactivity disorder (ADHD) product....
Please Login to read the full article.
06 April 2009
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Shire considers new patent infringement suit from Watson on Adderall XR
- Study: No increased cardiovascular risk found with ADHD drugs in adults
- US Capitol Capsule: Group proposes efforts to ensure US innovation competitiveness
- Shire ADHD alliance gives more power to Shionogi's diversifying lineup
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
